Skip to main content
NIH funding notice PAR-17-192

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)

Closed on May 7, 2020.

Posted
March 29, 2017
Close date
May 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $488,333 in first-year total cost, median $244,167.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 ETTN-G (50)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR1
Competing awards under PAR-17-192 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019MRI biosensors and complementary drug nanocarriers for effective image-guided drug delivery and early tumor response assessment of pediatric medulloblastomas1R21HD097357-01A1NGEN, ETHEL JOSOJOHNS HOPKINS UNIVERSITY, MD$261,083ZRG1
2018Aqueous-based Two-Step Spray Drying as a Taste Masking Drug Delivery Platform1R21HD095100-01FELTON, LINDA A.UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM$227,250ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.